• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性肺静脉狭窄:一项多中心研究的结果、危险因素及严重程度评分

Primary Pulmonary Vein Stenosis: Outcomes, Risk Factors, and Severity Score in a Multicentric Study.

作者信息

Kalfa David, Belli Emre, Bacha Emile, Lambert Virginie, di Carlo Duccio, Kostolny Martin, Salminen Jukka, Nosal Matej, Poncelet Alain, Horer Jurgen, Berggren Hakan, Yemets Illya, Hazekamp Mark, Maruszewski Bohdan, Sarris George, Pozzi Marco, Ebels Tjark, Lacour-Gayet François

机构信息

Department of Pediatric Cardiac Surgery, Morgan Stanley Children's Hospital of New York-Presbyterian, Columbia University Medical Center, New York, New York and Columbia University, New York, New York.

Department of Pediatric Cardiac Surgery, Marie Lannelongue Hospital, le Plessis Robinson, France.

出版信息

Ann Thorac Surg. 2017 Jul;104(1):182-189. doi: 10.1016/j.athoracsur.2017.03.022.

DOI:10.1016/j.athoracsur.2017.03.022
PMID:28633223
Abstract

BACKGROUND

Primary pulmonary vein stenosis (PPVS) still carries a poor prognosis, and prognostic factors remain controversial. The aim of this study was to determine outcomes and prognostic factors after PPVS repair in the current era.

METHODS

Thirty patients with PPVS and a normal pulmonary vein (PV) connection operated on in 10 European/North American centers (2000-2012) were included retrospectively. A specific PVS severity score was developed based on the assessment of each PV. Studied end points were death, PV reoperation, and restenosis. A univariate and multivariate risk analysis was performed.

RESULTS

The mean number of affected PVs per patient was 2.7 ± 1.1. Sutureless repair was used in 21 patients (70%), endovenectomy was used in 5 patients, and patch venoplasty was used in 4 patients. Overall PV restenosis, reoperation, and mortality occurred in 50%, 40%, and 30% of patients respectively. Freedom from mortality, reoperation, and restenosis at 8 years of follow-up was 70% ± 8%, 62% ± 8%, and 47% ± 9%, respectively. Restenosis and mortality rates after sutureless repair versus nonsutureless repair were 57% (n = 12 of 21) versus 33% (n = 3 of 9) (p = 0.42) for restenosis and 38% (n = 8 of 21) versus 11% (n = 1 of 9) (p = 0.21) for mortality. Patients selected for a sutureless technique were younger and smaller and had more severe disease before operation. A postoperative high PVS score and pulmonary hypertension 1 month after the operation were independent risk factors for restenosis (hazard ratio [HR], 1.34; p = 0.002 and HR, 6.81; p = 0.02, respectively), reoperation (HR, 1.24; p = 0.01 and HR, 7.60; p = 0.02), and mortality (HR, 1.39; p = 0.01 and HR, 39.5; p = 0.008).

CONCLUSIONS

Primary PVS still has a guarded prognosis in the current era despite adoption of the sutureless technique. Postoperative pulmonary hypertension and severity of disease evaluated by a new severity score are independent prognostic factors regardless of surgical technique.

摘要

背景

原发性肺静脉狭窄(PPVS)的预后仍然很差,预后因素仍存在争议。本研究的目的是确定当前时代PPVS修复后的结局和预后因素。

方法

回顾性纳入2000年至2012年在10个欧洲/北美中心接受手术的30例PPVS且肺静脉(PV)连接正常的患者。基于对每条PV的评估制定了特定的PVS严重程度评分。研究的终点是死亡、PV再次手术和再狭窄。进行了单因素和多因素风险分析。

结果

每位患者受影响的PV平均数量为2.7±1.1。21例患者(70%)采用了无缝合修复,5例患者采用了静脉内膜切除术,4例患者采用了补片静脉成形术。总体而言,分别有50%、40%和30%的患者发生PV再狭窄、再次手术和死亡。随访8年时无死亡、无再次手术和无再狭窄的生存率分别为70%±8%、62%±8%和47%±9%。无缝合修复与非无缝合修复后的再狭窄率分别为57%(21例中的12例)和33%(9例中的3例)(p=0.42),死亡率分别为38%(21例中的8例)和11%(9例中的1例)(p=0.21)。选择无缝合技术的患者更年轻、体型更小,术前疾病更严重。术后PVS评分高和术后1个月出现肺动脉高压是再狭窄(风险比[HR],1.34;p=0.002和HR,6.81;p=0.02)、再次手术(HR,1.24;p=0.01和HR,7.60;p=0.02)和死亡(HR,1.39;p=0.01和HR,39.5;p=0.008)的独立危险因素。

结论

尽管采用了无缝合技术,但在当前时代原发性PVS的预后仍然不佳。无论手术技术如何,术后肺动脉高压和通过新的严重程度评分评估的疾病严重程度都是独立的预后因素。

相似文献

1
Primary Pulmonary Vein Stenosis: Outcomes, Risk Factors, and Severity Score in a Multicentric Study.原发性肺静脉狭窄:一项多中心研究的结果、危险因素及严重程度评分
Ann Thorac Surg. 2017 Jul;104(1):182-189. doi: 10.1016/j.athoracsur.2017.03.022.
2
Outcomes and prognostic factors for postsurgical pulmonary vein stenosis in the current era.当前时代手术后肺静脉狭窄的结果和预后因素。
J Thorac Cardiovasc Surg. 2018 Jul;156(1):278-286. doi: 10.1016/j.jtcvs.2018.02.038. Epub 2018 Feb 23.
3
Clinical characteristics and prognostic factors of primary pulmonary vein stenosis or atresia in children.儿童原发性肺静脉狭窄或闭锁的临床特征及预后因素。
Ann Thorac Surg. 2013 Jan;95(1):229-34. doi: 10.1016/j.athoracsur.2012.08.104. Epub 2012 Oct 25.
4
Clinical Outcomes, Predictors, and Surgical Management of Primary Pulmonary Vein Stenosis.原发性肺静脉狭窄的临床转归、预测因素和外科治疗。
Ann Thorac Surg. 2022 Apr;113(4):1239-1247. doi: 10.1016/j.athoracsur.2021.03.015. Epub 2021 Mar 18.
5
Conventional and sutureless techniques for management of the pulmonary veins: Evolution of indications from postrepair pulmonary vein stenosis to primary pulmonary vein anomalies.肺静脉处理的传统技术与无缝合技术:适应证从修复后肺静脉狭窄到原发性肺静脉异常的演变
J Thorac Cardiovasc Surg. 2005 Jan;129(1):167-74. doi: 10.1016/j.jtcvs.2004.08.043.
6
Surgical repair of pulmonary venous stenosis: a word of caution.肺静脉狭窄的手术修复:一则警示
Ann Thorac Surg. 2014 Nov;98(5):1687-91; discussion 1691-2. doi: 10.1016/j.athoracsur.2014.05.082. Epub 2014 Aug 19.
7
Pulmonary vein stenosis: Severity and location predict survival after surgical repair.肺静脉狭窄:严重程度和位置可预测手术修复后的生存率。
J Thorac Cardiovasc Surg. 2016 Mar;151(3):657-666.e2. doi: 10.1016/j.jtcvs.2015.08.121. Epub 2015 Sep 16.
8
Surgical repair for primary pulmonary vein stenosis: Single-institution, midterm follow-up.外科修复原发性肺静脉狭窄:单中心,中期随访。
J Thorac Cardiovasc Surg. 2015 Jul;150(1):181-8. doi: 10.1016/j.jtcvs.2015.03.032. Epub 2015 Mar 28.
9
Management outcomes of primary pulmonary vein stenosis.原发性肺静脉狭窄的治疗结果。
J Thorac Cardiovasc Surg. 2020 Mar;159(3):1029-1036.e1. doi: 10.1016/j.jtcvs.2019.08.105. Epub 2019 Sep 25.
10
Primary sutureless repair for "simple" total anomalous pulmonary venous connection: midterm results in a single institution.单中心“单纯型”完全性肺静脉异位引流的直接吻合修复:中期结果
J Thorac Cardiovasc Surg. 2011 Jun;141(6):1346-54. doi: 10.1016/j.jtcvs.2010.10.056. Epub 2011 Mar 31.

引用本文的文献

1
Ten-Year Experience with Pediatric Pulmonary Vein Interventions: Adverse Events and Institutional Strategies for Safety.小儿肺静脉介入治疗十年经验:不良事件及安全的机构策略
Pediatr Cardiol. 2025 Jul 20. doi: 10.1007/s00246-025-03955-w.
2
Mortality Patterns in Pediatric Pulmonary Vein Stenosis: Insights Into Right Ventricular Systolic Pressure Associations.小儿肺静脉狭窄的死亡率模式:对右心室收缩压关联的见解
J Am Heart Assoc. 2025 Jan 21;14(2):e037908. doi: 10.1161/JAHA.124.037908. Epub 2025 Jan 17.
3
Management of Pediatric Pulmonary Vein Stenosis.
小儿肺静脉狭窄的管理
J Soc Cardiovasc Angiogr Interv. 2022 Jun 30;1(5):100391. doi: 10.1016/j.jscai.2022.100391. eCollection 2022 Sep-Oct.
4
Multimodal Assessment and Intramodal Comparison of Imaging Techniques for Pediatric Pulmonary Vein Stenosis with Pulmonary Hypertension.小儿肺静脉狭窄合并肺动脉高压的成像技术多模态评估及模态内比较
Pediatr Cardiol. 2025 Jun;46(5):1180-1184. doi: 10.1007/s00246-024-03531-8. Epub 2024 Jun 6.
5
Outcomes and Risk Factors of Interventions for Pediatric Post-operative Pulmonary Vein Stenosis.儿科术后肺静脉狭窄介入治疗的结果和危险因素。
Pediatr Cardiol. 2023 Dec;44(8):1778-1787. doi: 10.1007/s00246-023-03214-w. Epub 2023 Jul 9.
6
Combination Chemotherapy in Severe Pulmonary Vein Stenosis-A Case Series.重度肺静脉狭窄的联合化疗——病例系列
Children (Basel). 2023 Feb 11;10(2):364. doi: 10.3390/children10020364.
7
Losartan attenuates upstream vasculopathy in a modified piglet model of pulmonary vein stenosis: contribution of the Hippo pathway.氯沙坦减轻改良仔猪肺静脉狭窄模型中的上游血管病变:Hippo通路的作用
Ann Transl Med. 2022 Nov;10(21):1153. doi: 10.21037/atm-22-2621.
8
Association between pulmonary vein stenosis and necrotizing enterocolitis or gastrointestinal pathology: A case-control study.肺静脉狭窄与坏死性小肠结肠炎或胃肠道病变之间的关联:一项病例对照研究。
Ann Pediatr Cardiol. 2022 Jan-Feb;15(1):13-19. doi: 10.4103/apc.apc_210_21. Epub 2022 Jun 14.
9
Progress in Pulmonary Vein Stenosis: Lessons from Success in Treating Pulmonary Arterial Hypertension.肺静脉狭窄的进展:从肺动脉高压治疗成功中汲取的经验教训。
Children (Basel). 2022 May 29;9(6):799. doi: 10.3390/children9060799.
10
Prematurity and Pulmonary Vein Stenosis: The Role of Parenchymal Lung Disease and Pulmonary Vascular Disease.早产与肺静脉狭窄:肺实质疾病和肺血管疾病的作用
Children (Basel). 2022 May 12;9(5):713. doi: 10.3390/children9050713.